4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-000622
Chief Business Officer gave up 40,664 shares (to pay taxes)
- Chief Business Officer acquired 91,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loerop James Chief Business Officer | 2024-12-31 | Option exercise | +73,750 | 107,767 | D: show line 1 in the form | ||
| Loerop James Chief Business Officer | 2024-12-31 | Shares withheld for taxes | −32,089 | $2.48 | $79,581 | 75,678 | D: show line 2 in the form |
| Loerop James Chief Business Officer | 2025-01-02 | Option exercise | +18,150 | 93,828 | D: show line 3 in the form | ||
| Loerop James Chief Business Officer | 2025-01-02 | Shares withheld for taxes | −8,575 | $2.48 | $21,266 | 85,253 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loerop James Chief Business Officer | 2024-12-31 | Option exercise · Restricted Stock Units | −73,750 | 73,750 | D: show line 5 in the form | ||
| Loerop James Chief Business Officer | 2025-01-02 | Grant or award · Restricted Stock Units | +55,000 | 55,000 | D: show line 6 in the form | ||
| Loerop James Chief Business Officer | 2025-01-02 | Option exercise · Restricted Stock Units | −18,150 | 36,850 | D: show line 7 in the form |
Loading xslF345X05/form4-01032025_060104.xml…